Operation Warp Speed expects that the U.S. trials of vaccines made by AstraZeneca Plc and Johnson & Johnson to restart as soon as this week. The two companies developing Covid-19 vaccines backed by Operation Warp Speed temporarily halted their trials because participants fell ill, slowing down the race for a shot to halt the pandemic. J&J paused its trial last week when a participant got sick. AstraZeneca’s trial paused last month after a woman in the U.K. study developed neurological symptoms and the U.S. Food & Drug Administration has yet to clear the study to resume in the U.S. Johnson & Johnson is testing its vaccine in as many as 60,000 volunteers from Peru to South Africa. U.S. regulators have not put a clinical hold on J&J’s trial. British drugmaker Astra and partner the University of Oxford last month temporarily stopped tests of its own vaccine candidate after a trial participant fell ill. While the Astra study has remained halted in the U.S., where it is being evaluated by regulators, it has resumed in a number of other countries.
SOURCE: AL JAZEERA
More Stories
Las Vegas Resident’s Three-week Adventure through Egypt
Tunisia Needs “Deep Reforms” Such as Drastically Reducing its Vast Public Wage Bill
Credit Unions in Africa Switch to Fintech
Ghana’s Low Tax-to-GDP Ratio Makes it Hard to Finance its Developmental Agenda
Truck Delays at the Border Wreak Havoc for Uganda’s Fuel Users
Airlines Operating on the Continent Face Particular Challenges
The Inclusion of Rwanda as a Potential Relocation Destination for Migrants Raises Eyebrows
Sudanese Demand Return to Civilian Rule in Deadly Riots
Abuja Shows Off Impressive Rice Yield in Bid to Stop Rice Imports
Bain & Company Leaves South African Business Board
Economic Perks of Growing Cycling Culture in North Africa
The Bank of Uganda Lowers Limits on the Value of Cheque Payments to Promote e-payments